close

AspenBio Pharma, Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and marketing of drugs and diagnostics for human and animal healthcare. Its product pipeline includes AppyScore, which has completed 800 patient pivotal clinical trials for use as an aid in the diagnosis of appendicitis. The company also develops animal healthcare products focusing on reproduction, including BoviPure LH, a recombinant hormone analog that induces ovulation and reduces the risk of pregnancy loss in dairy cows; BoviPure FSH, a single-chain bovine FSH analog for super-ovulation of cows; EquiPure LH, a single-chain LH analog for horses that stimulates follicular development, as well as induces ovulation in estrous mares; and EquiPure FSH, a single-chain FSH analog for horses that assists mares through transition and for super-ovulation. In addition, it manufactures and markets approximately 20-30 purified protein products primarily for use as controls by diagnostic test kit manufacturers and research facilities to determine whether diagnostic test kits are functioning properly. The company was founded in 2000 and is based in Castle Rock, Colorado.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	0.72
Volume	21550
Volume Avg	47221
52 Week High	4.85
52 Week Low	0.58
PE	N/A
PE (group average)	N/A
EPS Year	-1.45
EPS change Q/Q	0%
EPS change Q/Q Yr ago	-30%
EPS change Q/Q next Q est	-81.58%
EPS change Y/Y	-58.06%
REV change Q/Q	0%
REV change Q/Q Yr ago	0%
EPS next Q est	-0.38
EPS next Y est	-1.44
Divident Annual	0.00
Dividend Yield	0%